| Primary |
| Asthma |
50.0% |
| Prophylaxis |
19.2% |
| Bronchitis |
7.7% |
| Drug Use For Unknown Indication |
7.7% |
| Bronchitis Chronic |
3.8% |
| Emphysema |
3.8% |
| Oral Candidiasis |
3.8% |
| Product Used For Unknown Indication |
3.8% |
|
| Cerebrovascular Accident |
16.7% |
| Psychotic Disorder |
16.7% |
| Tooth Disorder |
16.7% |
| Anosmia |
8.3% |
| Drug Exposure During Pregnancy |
8.3% |
| Lymphadenopathy |
8.3% |
| Psoriasis |
8.3% |
| Systemic Candida |
8.3% |
| Tremor |
8.3% |
|
| Secondary |
| Asthma |
37.5% |
| Product Used For Unknown Indication |
22.5% |
| Chronic Obstructive Pulmonary Disease |
15.0% |
| Prophylaxis |
7.5% |
| Diabetes Mellitus |
5.0% |
| Hypertension |
5.0% |
| Cerebrovascular Accident |
2.5% |
| Coronary Artery Disease |
2.5% |
| Migraine |
2.5% |
|
| Bronchopulmonary Aspergillosis Allergic |
30.0% |
| Cerebrovascular Accident |
30.0% |
| Neurological Decompensation |
10.0% |
| Paternal Drugs Affecting Foetus |
10.0% |
| Vascular Dementia |
10.0% |
| Weight Decreased |
10.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
54.4% |
| Drug Use For Unknown Indication |
9.6% |
| Asthma |
7.6% |
| Chronic Obstructive Pulmonary Disease |
3.7% |
| Prophylaxis |
2.9% |
| Hypertension |
2.8% |
| Depression |
1.9% |
| Rheumatoid Arthritis |
1.8% |
| Atrial Fibrillation |
1.6% |
| Pain |
1.6% |
| Prostate Cancer |
1.5% |
| Hiv Infection |
1.4% |
| Non-small Cell Lung Cancer Metastatic |
1.4% |
| Acute Graft Versus Host Disease |
1.3% |
| Schizophrenia |
1.3% |
| Cough |
1.2% |
| Infection Prophylaxis |
1.1% |
| Type 2 Diabetes Mellitus |
1.1% |
| Constipation |
0.9% |
| Oedema Peripheral |
0.9% |
|
| Wheezing |
10.4% |
| Pneumonia |
6.6% |
| Teeth Brittle |
6.6% |
| Contusion |
5.7% |
| Miosis |
5.7% |
| Psychomotor Hyperactivity |
5.7% |
| Transient Ischaemic Attack |
5.7% |
| Vomiting |
5.7% |
| White Blood Cell Count Increased |
5.7% |
| Lower Respiratory Tract Infection |
4.7% |
| Poor Quality Sleep |
4.7% |
| Vision Blurred |
4.7% |
| Withdrawal Syndrome |
4.7% |
| Decreased Appetite |
3.8% |
| Rash Generalised |
3.8% |
| Renal Impairment |
3.8% |
| Sepsis |
3.8% |
| Anaphylactic Reaction |
2.8% |
| Dyspnoea |
2.8% |
| General Physical Health Deterioration |
2.8% |
|